Frederieke H. Van Duijnhoven - Publications

A proof-of-concept study of optical tissue sensing during vacuum-assisted breast biopsy procedures.

Journal: Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy

Published: August 06, 2026

De-escalated chemotherapy and endocrine therapy outcomes in young women with stage I HR+/HER2+ breast cancer: An international real-world study.

Journal: Breast (Edinburgh, Scotland)

Published: March 24, 2026

Local ablative treatment and continuation of systemic therapy for oligoprogressive metastatic breast cancer: a retrospective cohort study.

Journal: Cancer treatment and research communications

Published: March 04, 2026

ASO Visual Abstract: The Value of Ultrasound in Patients with T1-T2 Breast Cancer with No Palpable Lymph Nodes Enrolled in the EORTC 10981-22023 AMAROS Trial.

Journal: Annals of surgical oncology

Published: January 24, 2026

ASO Author Reflections: The Added Value of Axillary Ultrasound in Early Breast Cancer: Insights from the AMAROS Trial.

Journal: Annals of surgical oncology

Published: December 15, 2025

Tailoring axillary treatment in patients with isolated locoregional recurrent breast cancer.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: September 15, 2025

The Value of Ultrasound in Patients with T1-T2 Breast Cancer with No Palpable Lymph Nodes Enrolled in the EORTC 10981-22023 AMAROS Trial.

Journal: Annals of surgical oncology

Published: September 10, 2025

Iodine Seed-Marking Protocol for Response-Guided Axillary Treatment After Systemic Therapy for Node-Positive Breast Cancer.

Journal: JAMA oncology

Published: August 28, 2025

Short-term complications of immediate implant-based breast reconstruction: Risk factor analyses and a novel cumulative risk algorithm.

Journal: Journal of plastic, reconstructive & aesthetic surgery : JPRAS

Published: June 23, 2025

Adjuvant ovarian function suppression and aromatase inhibitors in premenopausal patients with hormone receptor and HER2 positive breast cancer, by timing of chemotherapy and trastuzumab and response to neoadjuvant therapy.

Journal: Breast (Edinburgh, Scotland)

Published: June 03, 2025

Impact of routine FDG-PET/CT on locoregional treatment decisions in breast cancer patients receiving preoperative systemic therapy.

Journal: Breast (Edinburgh, Scotland)

Published: February 10, 2025

An early economic evaluation of active surveillance for low-risk ductal carcinoma in situ.

Journal: Future oncology (London, England)

Published: December 16, 2024